TCV-295

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTCV-295
Drug Alias NameTCV-295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A